KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested Capital

AbCellera Biologics (ABCL) Return on Assets (2021 - 2023)

Historic Return on Assets for AbCellera Biologics (ABCL) over the last 4 years, with Q3 2024 value amounting to 0.03%.

  • AbCellera Biologics' Return on Assets rose 500.0% to 0.03% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.03%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.11% for FY2024, which is 200.0% down from last year.
  • AbCellera Biologics' Return on Assets amounted to 0.03% in Q3 2024, which was up 500.0% from 0.05% recorded in Q2 2024.
  • Over the past 5 years, AbCellera Biologics' Return on Assets peaked at 0.26% during Q1 2021, and registered a low of 0.1% during Q4 2023.
  • Its 4-year average for Return on Assets is 0.06%, with a median of 0.1% in 2022.
  • As far as peak fluctuations go, AbCellera Biologics' Return on Assets tumbled by -2400bps in 2023, and later skyrocketed by 500bps in 2024.
  • Quarter analysis of 4 years shows AbCellera Biologics' Return on Assets stood at 0.12% in 2021, then decreased by -17bps to 0.1% in 2022, then crashed by -195bps to 0.1% in 2023, then surged by 66bps to 0.03% in 2024.
  • Its last three reported values are 0.03% in Q3 2024, 0.05% for Q2 2024, and 0.07% during Q1 2024.